2009
$50M
from 13 investors over 13 rounds
IMPACT Therapeutics, Inc. raised undisclosed on March 14, 2022
Investors: Lilly Asia Ventures, 深圳市鼎心资本管理有限公司, YUEXIU GROUP and Exome Asset Management
IMPACT Therapeutics, Inc. raised $50M on December 1, 2020
Investors: Lilly Asia Ventures and 浙江奥翔药业股份有限公司
IMPACT Therapeutics, Inc. raised $30M on August 3, 2018
Investors: Lilly Asia Ventures and Decheng Capital
IMPACT Therapeutics, Inc. raised $10M on February 22, 2016
Investors: Lilly Asia Ventures, 杭州海邦投资管理有限公司 and 广州越秀产业投资基金管理有限公司
IMPACT Therapeutics, Inc. raised undisclosed on July 7, 2014
Investors: Cenova Capital and Lilly Asia Ventures